GFB 111

Known as: GFB-111, GFB111 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2000-2000
024620002000

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2000
2000
We have designed a molecule, GFB-111, that binds to platelet-derived growth factor (PDGF), prevents it from binding to its… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?
Review
2000
Review
2000
This review describes our recent efforts in the development of novel therapies for cancer. Our primary approach is to design… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 6
Is this relevant?
2000
2000
promising area involves the design of smallmolecule inhibitors of growth factors active in malignancies. PDGF and its receptors… (More)
Is this relevant?
2000
2000
promising area involves the design of smallmolecule inhibitors of growth factors active in malignancies. PDGF and its receptors… (More)
Is this relevant?
2000
2000
promising area involves the design of smallmolecule inhibitors of growth factors active in malignancies. PDGF and its receptors… (More)
Is this relevant?
2000
2000
promising area involves the design of smallmolecule inhibitors of growth factors active in malignancies. PDGF and its receptors… (More)
Is this relevant?